Brief: Moberg Pharma Q2 Loss Widens To SEK 3.9 Mln

Moberg Pharma AB (publ)

09/08/2022 08:30

Aug 9 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * INTERIM REPORT JANUARY - JUNE 2022
    * Q2 EBITDA LOSS SEK 4.3 MILLION VERSUS LOSS SEK 3.5 MILLION
YEAR
AGO
    * Q2 LOSS AFTER TAX SEK 3.9 MILLION VERSUS LOSS SEK 3.3
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr2dbHtt 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))